![Cells | Free Full-Text | Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents Cells | Free Full-Text | Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents](https://www.mdpi.com/cells/cells-09-02589/article_deploy/html/images/cells-09-02589-g001.png)
Cells | Free Full-Text | Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents
![CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens | PNAS CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens | PNAS](https://www.pnas.org/cms/10.1073/pnas.1917182117/asset/5472f186-bfb9-4f52-9fa3-c0d6fe21b127/assets/graphic/pnas.1917182117fig01.jpeg)
CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens | PNAS
![The multiple faces of CD5 - Burgueño‐Bucio - 2019 - Journal of Leukocyte Biology - Wiley Online Library The multiple faces of CD5 - Burgueño‐Bucio - 2019 - Journal of Leukocyte Biology - Wiley Online Library](https://jlb.onlinelibrary.wiley.com/cms/asset/46f7fe4a-1a50-4429-a1f0-8ae79f488772/jlb10304-gra-0001-m.jpg?trick=1698562980575)
The multiple faces of CD5 - Burgueño‐Bucio - 2019 - Journal of Leukocyte Biology - Wiley Online Library
![CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases | Modern Pathology CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2015.42/MediaObjects/41379_2015_Article_BFmodpathol201542_Fig4_HTML.jpg)
CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases | Modern Pathology
![The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy](https://www.cell.com/cms/attachment/a7cc7bdc-13e1-4ea0-9ce1-243f8dee8b24/fx1_lrg.jpg)
The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy
![Frontiers | Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function Frontiers | Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function](https://www.frontiersin.org/files/Articles/584937/fimmu-11-584937-HTML/image_m/fimmu-11-584937-g001.jpg)
Frontiers | Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function
![Effect of CD5 enhancer deletion on CD5 expression on splenic T cells.... | Download Scientific Diagram Effect of CD5 enhancer deletion on CD5 expression on splenic T cells.... | Download Scientific Diagram](https://www.researchgate.net/publication/47791483/figure/fig5/AS:601636112199696@1520452635473/Effect-of-CD5-enhancer-deletion-on-CD5-expression-on-splenic-T-cells-Splenocytes-were.png)
Effect of CD5 enhancer deletion on CD5 expression on splenic T cells.... | Download Scientific Diagram
![CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels | Cellular & Molecular Immunology CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels | Cellular & Molecular Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41423-020-0490-z/MediaObjects/41423_2020_490_Fig1_HTML.png)
CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels | Cellular & Molecular Immunology
![Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations | Hematology, Transfusion and Cell Therapy Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations | Hematology, Transfusion and Cell Therapy](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//25311379/0000004200000003/v3_202009160753/S2531137919301324/v3_202009160753/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92xcqUtYYCc6yiYRjTD2AR3zJSEmH4GGT8A27de8H5QqAdccHlDwud9PYwTAyLTEDuwOiqSIbmQdF3kQjsu6ZxfmiEEQScQL0HaNU4BZ6JUmiNAe18YowduLzZpY6WeB6lJgNJxbrR34jguMIAGx+MMRIU9MG+/EPacfpihk7jdSOvDzZn0xDXWyCamRK5uMWFDK57MFioLhLXq4zFhD9lv34mSG86a6/F5odFfHb8uyPkKTi13t3zADyhuEHuhVTs5rHypMVsD8AR5XHnl0LNKIVgUF7OVvf/Y4piJZ3stY)
Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations | Hematology, Transfusion and Cell Therapy
![Regulation of CD5 expression during mouse and human T‐cell development.... | Download Scientific Diagram Regulation of CD5 expression during mouse and human T‐cell development.... | Download Scientific Diagram](https://www.researchgate.net/publication/349895159/figure/fig1/AS:11431281174338972@1689203924543/Regulation-of-CD5-expression-during-mouse-and-human-T-cell-development-A-Relative.png)
Regulation of CD5 expression during mouse and human T‐cell development.... | Download Scientific Diagram
![T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00898-z/MediaObjects/41392_2022_898_Fig1_HTML.png)
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy
![T-cell marker detections in B-cell lymphomas other than CLL/SLL and... | Download Scientific Diagram T-cell marker detections in B-cell lymphomas other than CLL/SLL and... | Download Scientific Diagram](https://www.researchgate.net/publication/315631731/figure/fig1/AS:475802266542082@1490451508470/T-cell-marker-detections-in-B-cell-lymphomas-other-than-CLL-SLL-and-MCL-Distribution-of.png)
T-cell marker detections in B-cell lymphomas other than CLL/SLL and... | Download Scientific Diagram
![CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity - Alotaibi - 2020 - European Journal of Immunology - Wiley Online Library CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity - Alotaibi - 2020 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0e7bf121-6aed-4521-8f66-3cc965ded438/eji4680-gra-0001-m.jpg?trick=1695150505589)
CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity - Alotaibi - 2020 - European Journal of Immunology - Wiley Online Library
![Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram](https://www.researchgate.net/publication/11360352/figure/fig2/AS:281749927022611@1444185825802/Expression-of-surface-membrane-markers-on-B-CLL-cells-and-normal-CD5-B-cells-Surface.png)
Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram
![Both CD5 + and CD5 -are negative for markers of activation, CD80 and... | Download Scientific Diagram Both CD5 + and CD5 -are negative for markers of activation, CD80 and... | Download Scientific Diagram](https://www.researchgate.net/publication/350913820/figure/fig3/AS:1019788902019079@1620148029992/Both-CD5-and-CD5-are-negative-for-markers-of-activation-CD80-and-CD86-directly-ex.png)
Both CD5 + and CD5 -are negative for markers of activation, CD80 and... | Download Scientific Diagram
![Frontiers | Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function Frontiers | Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function](https://www.frontiersin.org/files/MyHome%20Article%20Library/584937/584937_Thumb_400.jpg)